Last reviewed · How we verify
AZD9833 film-coated tablet A Dose 1
AZD9833 film-coated tablet A Dose 1 is a Small molecule drug developed by AstraZeneca. It is currently in Phase 1 development. Also known as: AZD9833 film-coated tablet phase 1.
At a glance
| Generic name | AZD9833 film-coated tablet A Dose 1 |
|---|---|
| Also known as | AZD9833 film-coated tablet phase 1 |
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AZD9833 film-coated tablet A Dose 1 CI brief — competitive landscape report
- AZD9833 film-coated tablet A Dose 1 updates RSS · CI watch RSS
- AstraZeneca portfolio CI
Frequently asked questions about AZD9833 film-coated tablet A Dose 1
What is AZD9833 film-coated tablet A Dose 1?
AZD9833 film-coated tablet A Dose 1 is a Small molecule drug developed by AstraZeneca.
Who makes AZD9833 film-coated tablet A Dose 1?
AZD9833 film-coated tablet A Dose 1 is developed by AstraZeneca (see full AstraZeneca pipeline at /company/astrazeneca).
Is AZD9833 film-coated tablet A Dose 1 also known as anything else?
AZD9833 film-coated tablet A Dose 1 is also known as AZD9833 film-coated tablet phase 1.
What development phase is AZD9833 film-coated tablet A Dose 1 in?
AZD9833 film-coated tablet A Dose 1 is in Phase 1.
Related
- Manufacturer: AstraZeneca — full pipeline
- Also known as: AZD9833 film-coated tablet phase 1
- Compare: AZD9833 film-coated tablet A Dose 1 vs similar drugs
- Pricing: AZD9833 film-coated tablet A Dose 1 cost, discount & access